132 related articles for article (PubMed ID: 17353720)
1. Selective drug taking during combination antiretroviral therapy.
Lanzafame M; Melotti R; Lattuada E; Boccafoglio F; Concia E; Verlato G; Vento S
J Acquir Immune Defic Syndr; 2007 Apr; 44(4):490-1. PubMed ID: 17353720
[No Abstract] [Full Text] [Related]
2. Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study.
Ledergerber B; Cavassini M; Battegay M; Bernasconi E; Vernazza P; Hirschel B; Furrer H; Rickenbach M; Weber R;
HIV Med; 2011 May; 12(5):279-88. PubMed ID: 20955356
[TBL] [Abstract][Full Text] [Related]
3. Intermediate highly active antiretroviral therapy adherence thresholds and empirical models for the development of drug resistance mutations.
Raffa JD; Tossonian HK; Grebely J; Petkau AJ; DeVlaming S; Conway B
J Acquir Immune Defic Syndr; 2008 Mar; 47(3):397-9. PubMed ID: 18398974
[No Abstract] [Full Text] [Related]
4. Use of anti-retrovirals in pediatric HIV infection.
Gaur S
Indian J Dermatol Venereol Leprol; 2008; 74(3):208-14. PubMed ID: 18583784
[No Abstract] [Full Text] [Related]
5. Validation of a self-reported questionnaire assessing adherence to antiretroviral medication.
Godin G; Gagné C; Naccache H
AIDS Patient Care STDS; 2003 Jul; 17(7):325-32. PubMed ID: 12952734
[TBL] [Abstract][Full Text] [Related]
6. To take or not to take: decision-making about antiretroviral treatment in people living with HIV/AIDS.
Kremer H; Ironson G; Schneiderman N; Hautzinger M
AIDS Patient Care STDS; 2006 May; 20(5):335-49. PubMed ID: 16706708
[TBL] [Abstract][Full Text] [Related]
7. Assessment of adherence to antiretroviral therapy in perinatally HIV-infected children and youth using self-report measures and pill count.
Farley JJ; Montepiedra G; Storm D; Sirois PA; Malee K; Garvie P; Kammerer B; Naar-King S; Nichols S;
J Dev Behav Pediatr; 2008 Oct; 29(5):377-84. PubMed ID: 18714204
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a practical method to assess antiretroviral adherence in HIV-infected Thai children.
Plipat N; Kottapat U; Komoltri C; Voradilokkul J; Anansakunwatt W; Chearskul P; Lapphra K; Phongsamart W; Chearskul S; Chokephaibulkit K; Vanprapar N
Southeast Asian J Trop Med Public Health; 2007 Sep; 38(5):828-34. PubMed ID: 18041298
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral therapy: need for a long-term view.
Maniar JK
Indian J Dermatol Venereol Leprol; 2006; 72(6):401-4. PubMed ID: 17179612
[No Abstract] [Full Text] [Related]
10. Monitoring of antiretroviral therapy in low-resource settings.
Bendavid E
Lancet; 2008 Jul; 372(9635):288-9; author reply 289. PubMed ID: 18657700
[No Abstract] [Full Text] [Related]
11. Fever and Rash in a Patient with HIV Infection.
Konheim A; Watts PJ; Tacastacas JD
Am Fam Physician; 2016 Oct; 94(8):658-660. PubMed ID: 27929236
[No Abstract] [Full Text] [Related]
12. Futility of CD4+ monitoring in HIV-1 patients with CD4+ cell count above 350 cells/μl on suppressive antiretroviral therapy.
Duncan CJ; Schmid ML; Schwab U; Price DA; Ong E
AIDS; 2014 Nov; 28(17):2638-9. PubMed ID: 25418545
[No Abstract] [Full Text] [Related]
13. A case for reduced frequency of CD4 count monitoring for children on combination antiretroviral therapy with consistently undetectable HIV viral load.
Johnson SM; Standing JF; Klein N; Irwin AD; Shingadia D; Lonsdale DO; Gilmour KC; Flynn J; Manns C; Clapson M; Bamford A
HIV Med; 2019 Apr; 20(4):e8-e9. PubMed ID: 30693658
[No Abstract] [Full Text] [Related]
14. The effect of primary drug resistance on CD4+ cell decline and the viral load set-point in HIV-positive individuals before the start of antiretroviral therapy.
Schultze A; Torti C; Cozzi-Lepri A; Vandamme AM; Zazzi M; Sambatakou H; De Luca A; Geretti AM; Sonnerborg A; Ruiz L; Monno L; Di Giambenedetto S; Gori A; Lapadula G;
AIDS; 2019 Feb; 33(2):315-326. PubMed ID: 30325769
[TBL] [Abstract][Full Text] [Related]
15. Initiating HIV therapy. Timing is critical, controversial.
Volberding PA
Postgrad Med; 2004 Feb; 115(2):15-8, 21, 24-6. PubMed ID: 15000057
[TBL] [Abstract][Full Text] [Related]
16. Zero CD4 count: a case of discordant CD4 response in a patient with well suppressed viral load.
Raja K; Chandrasekar C; Krishnarajasekhar OR; Manoharan G
Indian J Med Microbiol; 2013; 31(3):298-302. PubMed ID: 23883722
[TBL] [Abstract][Full Text] [Related]
17. Three-year outcome data of second-line antiretroviral therapy in Ugandan adults: good virological response but high rate of toxicity.
Castelnuovo B; John L; Lutwama F; Ronald A; Spacek LA; Bates M; Kamya MR; Colebunders R
J Int Assoc Physicians AIDS Care (Chic); 2009; 8(1):52-9. PubMed ID: 19095630
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of antiretroviral therapy in low-resource settings.
Walensky RP; Freedberg KA; Weinstein MC
Lancet; 2008 Jul; 372(9635):288; author reply 289. PubMed ID: 18657699
[No Abstract] [Full Text] [Related]
19. Quality of life after starting highly active antiretroviral therapy for chronic HIV-1 infection at different CD4 cell counts.
Nieuwkerk PT; Hillebrand-Haverkort ME; Vriesendorp R; Frissen PH; de Wolf F; Sprangers MA;
J Acquir Immune Defic Syndr; 2007 Aug; 45(5):600-1. PubMed ID: 17704686
[No Abstract] [Full Text] [Related]
20. CD4 Count Recovery After Initiation of Antiretroviral Therapy in Patients Infected With Human Immunodeficiency Virus.
Bishop JD; DeShields S; Cunningham T; Troy SB
Am J Med Sci; 2016 Sep; 352(3):239-44. PubMed ID: 27650226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
